ArticleHuman vaccines & immunotherapeutics2015
Using discrete choice modeling to evaluate the preferences and willingness to pay for leptospirosis vaccine.
Article in Human vaccines & immunotherapeutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Current Practices for Accounting for Preference Heterogeneity in Health-Related Discrete Choice Experiments: A Systematic Review.PharmacoEconomics · 2022Pooled it
- Vaccine preferences driving vaccine-decision making of different target groups: a systematic review of choice-based experiments.BMC infectious diseases · 2021Pooled it
- Discrete Choice Experiments in Health Economics: Past, Present and Future.PharmacoEconomics · 2019Pooled it
- Accounting for Scale Heterogeneity in Healthcare-Related Discrete Choice Experiments when Comparing Stated Preferences: A Systematic Review.The patient · 2018Pooled it
- Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China.Human vaccines & immunotherapeutics · 2024Article
- The main decision-making competence for willingness-to-pay towards COVID-19 vaccination: a family-based study in Taizhou, China.Annals of medicine · 2022Article
- Malaysian public preferences and decision making for COVID-19 vaccination: A discrete choice experiment.The Lancet regional health. Western Pacific · 2022Article
- The demand for a COVID-19 vaccine in Kenya.Human vaccines & immunotherapeutics · 2021Article
- Preference of influenza vaccination among the elderly population in Shaanxi province, China.Human vaccines & immunotherapeutics · 2021Article
- The demand for a COVID-19 vaccine in Ecuador.Vaccine · 2020Article
- Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia.Human vaccines & immunotherapeutics · 2020Article
- Parental Vaccine Preferences for Their Children in China: A Discrete Choice Experiment.Vaccines · 2020Article
- Adolescent values for immunisation programs in Australia: A discrete choice experiment.PloS one · 2017Article
Corrections and comments
- Erratum issuedCorrigendum.2016
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leptospirosis is highly endemic in the Philippines and a serious concern to public health. Local research on candidate vaccine is moving through the development pipeline. The availability of vaccines alone does not guarantee acceptance because individuals' vaccination choice decision is influenced by several factors. This study assessed how vaccine attributes and socio-demographic factors affect the acceptability of leptospirosis vaccine; and estimated individuals' willingness to pay for leptospirosis vaccine. A discrete choice experiment was conducted among leptospirosis and non-leptospirosis case respondents (n = 342) living in Metro Manila. Random Parameters Logit model was used to estimate the relative importance of vaccine attributes and socio-demographic variables on respondents' leptospirosis vaccination choice decision. The estimated model coefficients were used to derive implicit prices and willingness to pay for leptospirosis vaccine. Both case respondents preferred leptospirosis vaccine with 70-100% efficacy, mild to moderate risk of side-effects, given in a single shot, and at a lower price. Non-leptospirosis case respondents preferred a vaccine with 7 to 10 y of protection, while leptospirosis case respondents preferred a vaccine with 10 y protection. The probability of leptospirosis vaccination acceptance was affected by respondents' age, education, family size and income, proximity of home to rivers and sewers, and leptospirosis awareness level. Respondents' willingness to pay for leptospirosis vaccine (US$ 31.14-US$ 65.89) was higher than the Japanese retail price (US$ 21.60-US$ 24.00). Our findings indicated significant potential for introducing leptospirosis vaccine in the Philippine vaccine market. Delivery strategies to ensure equitable access to future leptospirosis vaccine are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.